EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayoz, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayoz, D.

Eur J Cardiothorac Surg 2007;31:412-413. doi:10.1016/j.ejcts.2007.01.010
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Editorial comment

Time course of the inflammatory response after endovascular repair of aortic aneurysms

Daniel Hayoz*

Internal Medicine and Vascular Medicine Department, Hôpital Cantonal Fribourg, 1700 Fribourg, Switzerland

* Corresponding author. Tel.: +41 26 4267254; fax: +41 26 4267251. (Email: hayozd{at}hopcantfr.ch).

Endovascular repair of aortic aneurysms is becoming an interesting alternative to open surgery in a subset of patients (elderly with several co-morbidities). Ongoing trials are underway in order to obtain head to head comparison of the performance of both methods. Recent reports (EVAR 1–2 and DREAM) have produced results that tend to demonstrate better mortality rate in the early phase (30 days) with a progressive loss of the benefit with time (after 2 years) [1,2]. The second observation that can be drawn from the publications is a greater number of complications in the endovascular repair group than in the open surgery group. These conclusions for the time being suggest that endovascular repair should be reserved for a subset of patients whose anatomy allows stent implantation and who following thorough investigations and information accept the late inconvenience of the endovascular approach.

One of the main differences between the two methods is the fate of the aneurysmal pouch, which is removed during open surgery and is left in place with endovascular repair. It has been demonstrated that endovascular stent grafting was followed by an acute phase inflammatory response (endotoxinemia, CRP and white blood cell count) that was of a lesser magnitude than the one observed after open surgery. Several mechanisms have been implicated as potential triggers of the inflammatory reaction following stent-graft implantation. They have been related to either the stent-graft itself or to the local reactions of the vessel wall (endothelial reaction with activation of the coagulation cascade) [3–4].

In the long term, the reaction of the aneurysmal pouch may also contribute to the perpetuation of an inflammatory reaction or to the extension of the aneurysmal process. A few years ago Sangiorgi et al. [5] have nicely demonstrated that metalloproteinases (MMPs), which contribute to the degradation of the matrix proteins in the aortic wall, could still present a certain degree of activity that was related to the fate of the endovascular repair. Indeed, patients with plasma levels of MMPs that did not return to basal levels were more prone to develop endoleaks and aneurysm expansion. However, MMPs appear to remain elevated for at least three months in open surgery while they return to baseline more rapidly following endovascular graft implantation [6]. Other markers of potential predictive value were tested for the detection of potential endoleak development following stent-graft treatment. Cross-linked fibrin degradation products (D-Dimer) appear to offer such an interesting potential in this surgical population. An increase in D-Dimer after endovascular treatment allowed identification of patients with endoleaks [7].

In the context of the inflammatory response caused by stent-graft repair of aortic aneurysm, Gabriel et al. [8] provide an interesting study looking at the time course of several relevant parameters involved in the inflammatory reaction after endovascular repair of aortic aneurysm repair. They have looked at the immediate, sub acute and late phase, changes of the different mediators and effectors of the inflammation. This carefully performed study will provide a benchmark for the evaluation of the inflammatory reactions following endovascular repair of aortic aneurysm. Unfortunately, the limited number of patients included in the study does not allow drawing any conclusion on the potential predictive value of the markers that were investigated. If further studies in this domain are to be planned, the addition of D-Dimer assay in the panel of the markers would be of great interest both for its potential predictive value and because it is a widely accessible marker in most clinical settings.

This study provides a nice illustration of the kinetics of events that occur after stent implantation. The elevation of IL-6 which culminates at 24 h triggers both an elevation of CRP and the development of fever 24 h later. The erythrocyte sedimentation rate follows the same trend with a lag time of a few days.

Future trials will help the medical community defining the patient population that will benefit most from endovascular repair. Once treated, the patients will have to undergo repeated controls to assess aneurysm tightness and lack of expansion. The monitoring of pertinent inflammatory markers may reduce the need for expensive imaging techniques in this regard. The study by Gabriel et al. provides a valuable dataset that will be useful for the design of future studies aimed at defining the best predictor of successful aortic aneurysm repair by the endovascular approach.


    References
 Top
 References
 

  1. EVAR trial participant Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial2): randomised controlled trial. Lancet 2005;365:2187-2192.[CrossRef][Medline]
  2. Blankensteijn JD, de Jong SE, Prinssen M, van der Ham AC, Buth J, van Sterkenburg SM, Verhagen HJ, Buskens E, Grobbee DE, Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 2005;352:2398-2405.[Abstract/Free Full Text]
  3. Hayoz D, Do DD, Mahler F, Triller J, Spertini F. Acute inflammatory reaction associated with endoluminal bypass grafts. J Endovasc Surg 1997;4:354-360.[CrossRef][Medline]
  4. Bolke E, Jehle PM, Storck M, Braun C, Schams S, Steinbach G, Orth K, Gorich J, Scharrer-Pamler R, Sunder-Plassmann L. Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome. Clin Chim Acta 2001;314:203-207.[CrossRef][Medline]
  5. Sangiorgi G, D’Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, Trimarchi S, Tolva V, Nano G, Rampoldi V, Spagnoli LG, Inglese L. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001;104:1288-1295.
  6. Lorelli DR, Jean-Claude JM, Fox CJ, Clyne J, Cambria RA, Seabrook GR, Towne JB. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg 2002;35:916-922.[CrossRef][Medline]
  7. Serino F, Abeni D, Galvagni E, Sardella SG, Scuro A, Ferrari M, Ciarafoni I, Silvestri L, Fusco A. Noninvasive diagnosis of incomplete endovascular aneurysm repair: D-dimer assay to detect type I endoleaks and nonshrinking aneurysms. J Endovasc Ther 2002;9:90-97.[CrossRef][Medline]
  8. Gabriel EA, Locali RF, Romano CC, da Silva Duarte AJ, Palma JH, Buffolo E. Analysis of the inflammatory response in endovascular treatment of aortic aneurysms. Eur J Cardiothorac Surg 2007;31:406-413.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayoz, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayoz, D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS